Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
| ▸ | TPH1 | P17752 | 2/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 3/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.42 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Tyrosine Ethylester SCHEMBL242946 | 0.97 | SLC7A5 (0.61) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL242947 | 0.97 | SLC7A5 (0.61) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL9327871 | 0.97 | SLC7A5 (0.61) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL595118 | 0.95 | SLC7A5 (0.59) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL9331146 | 0.95 | SLC7A5 (0.59) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL595119 | 0.95 | SLC7A5 (0.59) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL1532619 | 0.94 | SLC7A5 (0.57) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL27732314 | 0.94 | SLC7A5 (0.57) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL30772131 | 0.94 | SLC7A5 (0.57) | SLC7A5TPH1TAAR1SLC6A2ESR1 | |
| L-Tyrosine Ethylester SCHEMBL27074524 | 0.94 | SLC7A5 (0.57) | SLC7A5TPH1TAAR1SLC6A2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1905763-B1 | N-ACYLIC AMINOACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM OF ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS | NEBOLSIN VLADIMIR EVGENIEVICH (RU) | 2019-05-08 | — | — | EP | disclosed |
| US-8940780-B2 | N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form anti-allergic, anti-inflammatory and hypolipidemic agents | OTKRYTOE AKTSIONERNOE OBSCHESTVO OTECHESTVENNYE LEKARSTVA (RU) | 2015-01-27 | — | — | US | disclosed |
| US-8318950-B2 | N-acyl amino acid derivatives, a method for the preparation thereof, a pharmaceutical composition and use thereof as anti-allergic, anti-inflammatory and hypolipidemic agents | Otkrytoe Aktsionernoe Obschestvo-Otechestvennye Lekarstva (RU) | 2012-11-27 | — | — | US | disclosed |
| US-20100267962-A1 | N-ACYLIC AMINOACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS | Nebolsin, Vladimir Evgenievich (RU) | 2010-10-21 | — | — | US | disclosed |
| US-20080319040-A1 | N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents | OTKRYTOE AKTSIONERNOE OBSCHESTVO "OTECHESTVENNYE LEKARSTVA (RU) | 2008-12-25 | — | — | US | disclosed |
| EP-1905763-A1 | N-ACYLIC AMINOACID DERIVATIVES. METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM OF ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS | Nebolsin, Vladimir Evgenievich (RU) | 2008-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267962-A1 | N-ACYLIC AMINOACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS | HRH4, HRH2, AADAT | SLC7A5 357/4885TPH1 479/4885TAAR1 602/4885 |
| US-20080319040-A1 | N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents | HRH4, HRH2, AADAT | SLC7A5 357/4885TPH1 479/4885TAAR1 602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.